SCHEMBL23405296

SCHEMBL23405296

Cc1cc2c(Cl)ncnc2n1[C@H]1[C@@H]2OC(C)(C)O[C@@H]2[C@]2(CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)C[C@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23405208 0.81 ADORA3 (0.33) —
SCHEMBL23430004 0.81 ADORA3 (0.33) —
SCHEMBL31350170 0.77 HRH2 (0.43) —
SCHEMBL31350094 0.76 HRH2 (0.34) —
SCHEMBL31350143 0.75 ADORA3 (0.38) —
SCHEMBL21685924 0.72 PRMT5 (0.32) —
SCHEMBL21683387 0.72 PRMT5 (0.32) —
SCHEMBL23429993 0.72 — —
SCHEMBL23405284 0.72 — —
SCHEMBL23429861 0.72 HRH2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11952380-B2 Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors LUPIN LIMITED (IN) 2024-04-09 — — US disclosed
US-11459330-B2 Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors LUPIN LIMITED (IN) 2022-10-04 — — US disclosed
US-20220267339-A1 SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS LUPIN LIMITED (IN) 2022-08-25 — — US disclosed
US-20210163486-A1 SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS LUPIN LIMITED (IN) 2021-06-03 — — US disclosed
Send feedback